SCHEMBL7110705

SCHEMBL7110705

FC(F)(F)c1ccc(Br)nc1Br

nearest known ligand 0.34

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CFTR P13569 2/20 0.34
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
NOTUM Q6P988 2/20 0.31
AXL P30530 1/20 0.31
TRPA1 O75762 3/20 0.30
TRPM8 Q7Z2W7 1/20 0.30
TRPV1 Q8NER1 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8135554 0.77 CYP11B1 (0.37) CFTRCYP11B1CYP11B2NOTUM
SCHEMBL22028785 0.77 KDM4E (0.44) CFTR
SCHEMBL8778829 0.76 CYP3A4 (0.33)
SCHEMBL21945909 0.73 ULK1 (0.39) CFTRCYP11B1CYP11B2NOTUMTRPA1
SCHEMBL8136374 0.73 ALDH1A1 (0.49) CFTR
SCHEMBL15820311 0.71 NOTUM (0.33) CFTRCYP11B1CYP11B2NOTUM
SCHEMBL24649301 0.69 CYP1A2 (0.32) CFTR
SCHEMBL31532450 0.69 CDK1 (0.38) CYP11B2NOTUMTRPA1
SCHEMBL24649406 0.68
SCHEMBL1205413 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3974166-A FUNGICIDE CIBA-GEIGY CORPORATION (US) 1976-08-10 US claimed
EP-2934536-B1 FACTOR IXa INHIBITORS MERCK SHARP & DOHME (US) 2017-09-27 EP disclosed
US-9695198-B2 Factor IXa inhibitors MERCK SHARP & DOHME CORP. (US) 2017-07-04 US disclosed
US-20150368269-A1 Factor IXa Inhibitors MERCK SHARP & DOHME CORP. (US) 2015-12-24 US disclosed
EP-2934536-A1 FACTOR IXa INHIBITORS Merck Sharp & Dohme Corp. (US) 2015-10-28 EP disclosed
WO-2014099694-A1 FACTOR IXa INHIBITORS MERCK SHARP & DOHME CORP. (US) 2014-06-26 WO disclosed
EP-0949248-B1 6-(NONSUBSTITUTED OR SUBSTITUTED) PHENOXYPICOLINIC ACIDS, PROCESS OF PREPARING THE SAME, AND AGRICULTURAL/HORTICULTURAL GERMICIDES CONTAINING THE SAME KUREHA CHEMICAL IND CO LTD (JP) 2003-10-08 EP disclosed
US-6200933-B1 LOW TOXICITY TO HUMANS AND CATTLE KUREHA KAGAKU KABUSHIKI KAISHA (JP) 2001-03-13 US disclosed
EP-0949248-A1 6-(NONSUBSTITUTED OR SUBSTITUTED) PHENOXYPICOLINIC ACIDS, PROCESS OF PREPARING THE SAME, AND AGRICULTURAL/HORTICULTURAL GERMICIDES CONTAINING THE SAME KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) 1999-10-13 EP disclosed
US-4521603-A Continuous process for the production of polybromopyridine compounds OLIN CORPORATION (US) 1985-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150368269-A1 Factor IXa Inhibitors F9, TFPI, F13B CFTR 776/4885CYP11B1 1621/4885CYP11B2 2090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.